Neurocrine Biosciences
NBIX
#1452
Rank
$14.76 B
Marketcap
$148.12
Share price
2.15%
Change (1 day)
8.12%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company